Bellefontaine Healthcare: Medication Reconciliation Failure - CA
Ampicillin is a penicillin-type antibiotic. Giving it to someone with a known penicillin allergy is the kind of error that medication reconciliation, the process of carefully comparing a patient's medications before and after a care transition, exists specifically to prevent.
Federal inspectors visited the facility on August 27, 2025, following a complaint. What they found was a breakdown at one of the most predictable and preventable moments in nursing home care: the transition back from the hospital.
The facility's own Director of Nursing acknowledged the failure directly. According to the inspection report, the DON stated that staff should have reconciled the ampicillin order accurately and completely when Resident 1 was readmitted on August 1. The DON further acknowledged that the order should not have been placed at all once staff learned of the resident's penicillin allergy history, rather than simply continuing it without review.
That admission captures the two-part failure inspectors documented. First, the allergy wasn't caught before the order went in. Second, once someone did identify the penicillin allergy history, the order still wasn't corrected the way it should have been.
The facility had a written policy on exactly this situation. Its Reconciliation of Medications on Admission policy, last revised in July 2017, described the purpose plainly: to ensure medication safety by accurately accounting for a resident's medications, routes, and dosages upon admission. The policy required staff to compare pre-discharge medications to post-discharge medications and create a complete list that included drug name, dosage, frequency, route, and the reason the medication was prescribed. The stated goal was to prevent unintended changes or omissions at transition points in care.
The policy went further. It specified that medication reconciliation helps ensure that medications, routes, and dosages have been accurately communicated to the attending physician and care team, and that it reduces medication errors and enhances resident safety by making sure needed medications continue without interruption and in the correct form.
The gap between that written policy and what happened to Resident 1 on August 1 is what inspectors cited.
Inspectors rated the violation at a level of minimal harm or potential for actual harm, with few residents affected. That designation reflects the regulatory finding, but it doesn't fully describe what was at stake. Penicillin allergy reactions range from mild rash to anaphylaxis, a severe, potentially life-threatening response that can include throat swelling, a sudden drop in blood pressure, and loss of consciousness. The inspection report does not describe what, if any, reaction Resident 1 experienced.
What the record does show is that a resident came back to a facility that already held their medical history, a facility with a written policy designed for this exact moment, and still received a medication that their allergy history flagged as a risk. The reconciliation process that was supposed to catch that didn't.
Medication reconciliation failures at care transitions are among the most consistently documented problems in nursing home inspections nationally. The moment a resident moves between settings, from hospital to facility or facility to hospital and back, is when errors are most likely to enter the record. A missed allergy. A discontinued medication that gets restarted. A dosage that changed in the hospital but never updated at the facility. The Bellefontaine situation was the first kind.
The Director of Nursing's own words to inspectors made clear that the facility understood what the standard was and that staff had not met it. The ampicillin order should have been reconciled accurately and completely. It wasn't.
Resident 1 was being treated for an infection. Whether that infection was ultimately treated effectively, and what the resident's condition was after the ampicillin order was placed, the inspection report does not say.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for The Bellefontaine Healthcare Center from 2025-08-27 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 10, 2026 · Our methodology
THE BELLEFONTAINE HEALTHCARE CENTER in PASADENA, CA was cited for violations during a health inspection on August 27, 2025.
Ampicillin is a penicillin-type antibiotic.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.